Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 3:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2401–2424 of 6,936 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control, small Clear all

Conditions: Labor Complication
Interventions: Continue Oxytocin, Discontinue Oxytocin; Drug · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Pregnancy Related, Stress, Psychological, Glucose Intolerance During Pregnancy, Emotional Stress, Postprandial Hyperglycemia, Insulin Sensitivity/Resistance
Interventions: Psychosocial stress, Control non-stress; Behavioral
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 2
States / cities: Irvine, California • Orange, California

Conditions: Heart Failure With Reduced Ejection Fraction
Interventions: JK07, Matching Placebo; Drug
Lead sponsor: Salubris Biotherapeutics Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 7
States / cities: Tucson, Arizona • Stanford, California • Boston, Massachusetts + 4 more

Conditions: Insomnia, Sleep-Disordered Breathing
Interventions: AirCurve 10 ASV; Device
Lead sponsor: ResMed; Industry
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Body Image, Eating Disorder Symptom
Interventions: EVERYbody Project, Video + Expressive Writing; Behavioral · Other
Lead sponsor: Western Washington University; Other
Eligibility: 18 Years and older
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Bellingham, Washington

Conditions: Insomnia
Interventions: Dexmedetomidine, Zolpidem; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 35 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anger, Smoking Cessation
Interventions: Anger Reduction Treatment, Control Condition; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Healthy, Exercise-Induced Lactic Acidemia
Interventions: Treadmill Exercise, Cooling Gloves, Microbiome Capsule; Other · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Erectile Dysfunction Following Radical Prostatectomy, Urinary Incontinence of Non-organic Origin
Interventions: Viberect device; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 40 Years to 70 Years · Male only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 2
States / cities: Baltimore, Maryland • Frederick, Maryland

Conditions: Unruptured Brain Arteriovenous Malformation, Ruptured Brain Arteriovenous Malformation, Arteriovenous Malformations, AVM, BAVM
Interventions: Neurosurgery, Radiation therapy, Embolization; Procedure · Radiation
Lead sponsor: Centre hospitalier de l'Université de Montréal (CHUM); Other
Eligibility: 5 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2036
U.S. locations: 3
States / cities: Jacksonville, Florida • Boston, Massachusetts • Albuquerque, New Mexico

Conditions: Pain, Chronic
Interventions: Experimental: Group #1: Virtual Reality Headset, Group 2 No Virtual Reality Headset; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes Mellitus, Type 1
Interventions: IMCY-0098 450 μg, IMCY-0098 1350 μg, Placebo; Drug
Lead sponsor: Imcyse SA; Industry
Eligibility: 18 Years to 44 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: Birmingham, Alabama • Aurora, Colorado • Chicago, Illinois + 1 more

Conditions: Gait
Interventions: Gait Training, Functional electrical stimulation (FES), Peripheral electrical stimulation paired with cortical magnetic stimulation pulses; Other · Device
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Infections, Respiratory Tract
Interventions: GSK2140944, GSK2140944 placebo, Moxifloxacin, Moxifloxacin placebo; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Labor Long
Interventions: Oxytocin (Low dose), Oxytocin (High dose); Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Diabetes Mellitus, Gestational Diabetes Mellitus (GDM)
Interventions: GDM Enhanced, Meals; Behavioral
Lead sponsor: California Polytechnic State University-San Luis Obispo; Other
Eligibility: 18 Years and older · Female only
Enrollment: 978 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 3
States / cities: San Luis Obispo, California • Chicago, Illinois • Providence, Rhode Island

Conditions: Myocardial Ischemia, Critical Illness, Endothelial Dysfunction
Interventions: Day Light, Placebo light, ICU Intense Light, ICU Placebo light; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 90 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Delirium, Locally Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm
Interventions: Haloperidol, Lorazepam, Placebo, Quality-of-Life Assessment, Questionnaire Administration; Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 2
States / cities: Houston, Texas • Richmond, Virginia

Conditions: Breast Cancer
Interventions: Bupivacaine, patient-reported pain scores, saline; Drug · Behavioral · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Repetitive Negative Thinking, Serious Mental Illness Symptoms
Interventions: Mindfulness Training, Active mindfulness-based neurofeedback (Active mbNF), Sham mindfulness-based neurofeedback; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 14 Years to 21 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Disorder, Pre Diabetes, Obstructive Sleep Apnea
Interventions: Lifestyle Intervention; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pain, Acute Pain
Interventions: Pain Psychoeducation, Mindful Pain Management; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years and older
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Quality of Life, Health Promotion, Blood Pressure Monitoring, Self
Interventions: Conversations Advancing Resilience and Empowerment (CARE); Behavioral
Lead sponsor: University of Texas Rio Grande Valley; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Edinburg, Texas • Houston, Texas

Conditions: Childhood Obesity
Interventions: Social Support, Nutrition Session, Physical Activity Session; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 9 Years to 11 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Brooklyn, New York

Search by objective public record fields.

The Role of Oxytocin in the Second Stage of Labor

Emotion-Diet Interactions in Pregnancy

Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)

CPAP vs ASV for Insomnia

Expert Peer Facilitation of the EVERYbody Project

Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep

Computerized Anger-Reduction Treatment for Smoking Cessation

Microbiome Sampling During Endurance Exercise

Viberect Penile Vibratory Stimulation to Enhance Recovery of Erectile Function and Urinary Continence Post-Prostatectomy

Treatment of Brain AVMs (TOBAS) Study

VR and Cooled Genicular Nerve Radio Frequency Ablation for Chronic Knee Pain

IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)

AB Gait Estim Neurophysiology

Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor

Lifestyle Interventions to Prevent Diabetes in U.S. Home Visiting Programs

Bright Light Exposure in Surgical Patients

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

Mindfulness-based Neurofeedback to Reduce Negative Thinking in CHARMS Adolescents

Recruitment Strategies Comparing Different Strategies in Sleep Apnea and Prediabetes

Does Choice Improve the Pain Relief Derived From a Brief Intervention

A Randomized Control Trial of Conversations Advancing Resilience and Empowerment (CARE) Intervention

Healthy Families: Transforming Care for Obese Children at NYU Lutheran Family Health Centers